Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06649751, an oral dopamine D1/D5 agonist, in Parkinson's disease: A single ascending dose study

Authors
Category Primary study
JournalParkinsonism and Related Disorders
Year 2018
This article has no abstract
Epistemonikos ID: d8feb8d61bc19670f37faa6f149f4d0bc0586e8c
First added on: Feb 09, 2025